Mapping of the minimal domain encoding a conformational epitope by λ phage surface display: Factor VIII inhibitor antibodies from haemophilia A patients

Journal of Immunological Methods

Volumn 224, Issue 1-2, 1999, Pages 89-99

  Kuwabara, Ichiro ^a   Maruyama, Hiroko ^a   Kamisue, Seiki ^b   Shima, Midori ^b   Yoshioka, Akira ^b   Maruyama, Ichi N ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Affinity selection; Bacteriophage ; Fusion protein; Surface expression

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; HYBRID PROTEIN;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIOPHAGE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; DISULFIDE BOND; EPITOPE MAPPING; HEMOPHILIA A; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; SITE DIRECTED MUTAGENESIS; X RAY CRYSTALLOGRAPHY;

ABSORPTION; BACTERIOPHAGE LAMBDA; BASE SEQUENCE; CYSTEINE; DISULFIDES; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FACTOR VIII; GENE LIBRARY; GENETIC VECTORS; HEMOPHILIA A; HUMANS; ISOANTIBODIES; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE ANALYSIS, DNA; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIOPHAGE LAMBDA;

EID: 0033056797     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00012-5     Document Type: Article

References (58)

1. Amit A.G., Mariuzza R.A., Phillips S.E.V., Poljak R.J. Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science. 233:1986;747.
2. Arai M., Scandella D., Hoyer L.W. Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J. Clin. Invest. 83:1989;1978.
3. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K., 1987. Current Protocols in Molecular Biology, Wiley-Interscience, New York.
4. Cadwell R.C., Joyce G.F. Mutagenic PCR. PCR Methods Applic. 3:1994;S136.
5. Cameron C., Notley C., Hoyle S., McGlynn L., Hough C., Kamisue S., Giles A., Lillicrap D. The canine factor VIII cDNA and 5′ flanking sequence. Thromb. Haemost. 79:1998;317.
6. Cortese R., Monaci P., Nicosia A., Luzzago A., Felici F., Galfré G., Pessi A., Tramontano A., Sollazzo M. Identification of biologically active peptides using random libraries displayed on phage. Curr. Opin. Biotechnol. 6:1995;73.
7. Davies D.R., Cohen G.H. Interactions of protein antigens with antibodies. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7.
8. Derman A.I., Prinz W.A., Belin D., Beckwith J. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science. 262:1993;1744.
9. Dunn I.S. Assembly of functional bacteriophage lambda virions incorporating C-terminal peptide or protein fusions with the major tail protein. J. Mol. Biol. 248:1995;497.
10. Ehrenforth S., Kreuz W., Scharrer I., Linde R., Funk M., Güngör T., Krackhardt B., Kornhuber B. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet. 339:1992;594.
11. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 8:1971;871.
12. Fack F., Hügle-Dörr B., Song D., Queitsch I., Petersen G., Bautz E.K.F. Epitope mapping by phage display: random versus gene-fragment libraries. J. Immunol. Methods. 206:1997;43.
13. Fay P.J., Haidaris P.J., Smudzin T.M. Human factor VIIIa subunit structure. Reconstitution of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J. Biol. Chem. 266:1991;8957.
14. Fijnvandraat K., Celie P.H.N., Turenhout E.A.M., ten Cate J.W., van Mourik J.A., Mertens K., Peters M., Voorberg J. A human alloantibody interferes with binding of factor IXa to the factor VIII light chain. Blood. 91:1998;2347.
15. Fodor S.P.A., Read J.L., Pirrung M.C., Stryer L., Lu A.T., Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science. 251:1991;767.
16. Foster P.A., Fulcher C.A., Houghten R.A., Zimmerman T.S. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood. 75:1990;1999.
17. Fulcher C.A., de Graaf Mahoney S., Zimmerman T.S. FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting. Blood. 69:1987;1475.
18. Geysen H.M., Rodda S.J., Mason T.J., Tribbick G., Schoofs P.G. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods. 102:1987;259.
19. Healey J.F., Lubin I.M., Nakai H., Saenko E.L., Hoyer L.W., Scandella D., Lollar P. Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII. J. Biol. Chem. 270:1995;14505.
20. Jespers L., Jenné S., Lasters I., Collen D. Epitope mapping by negative selection of randomized antigen libraries displayed on filamentous phage. J. Mol. Biol. 269:1997;704.
21. Jin L., Fendly B.M., Wells J.A. High resolution functional analysis of antibody-antigen interactions. J. Mol. Biol. 226:1992;851.
22. Kuwabara I., Maruyama H., Mikawa Y.G., Zuberi R.I., Liu F.-T., Maruyama I.N. Efficient epitope mapping by bacteriophage lambda surface display. Nature Biotechnol. 15:1997;74.
23. Loomans E.E., Nijholt L.J., Cremers A.J., Paulij W.P., Schielen W.J. Epitope mapping and serodiagnosis using Ata- and (Lys)7 peptides. Biochim. Biophys. Acta. 1379:1998;273.
24. Lubin I.M., Healey J.F., Barrow R.T., Scandella D., Lollar P. Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis. J. Biol. Chem. 272:1997;30191.
25. Luzzago A., Felici F., Tramontano A., Pessi A., Cortese R. Mimicking of discontinuous epitopes by phage-displayed peptides: I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene. 128:1993;51.
26. Malik P., Terry T.D., Gowda L.R., Langara A., Petukhov S.A., Symmons M.F., Welsh L.C., Marvin D.A., Perham R.N. Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage. J. Mol. Biol. 260:1996;9.
27. Maruyama I.N., Maruyama H.I., Brenner S. Lambda foo: a lambda phage vector for the expression of foreign proteins. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8273.
28. Maruyama I.N., Mikawa Y.G., Maruyama H.I. A model for transmembrane signalling by the aspartate receptor based on random-cassette mutagenesis and site-directed disulfide cross-linking. J. Mol. Biol. 253:1995;530.
29. McMullen B.A., Fujikawa K., Davie E.W., Hedner U., Ezban M. Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A). Protein Sci. 4:1995;740.
30. Mehra V., Sweetser D., Young R.A. Efficient mapping of protein antigenic determinants. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7013.
31. Mikawa Y.G., Maruyama I.N., Brenner S. Surface display of proteins on bacteriophage lambda heads. J. Mol. Biol. 262:1996;21.
32. Paterson Y., Englander S.W., Roder H. An antibody binding site on cytochrome c defined by hydrogen exchange and two-dimensional NMR. Science. 249:1990;755.
33. Petersen G., Song D., Hügle-Dörr B., Oldenburg I., Bautz E.K.F. Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries. Mol. Gen. Genet. 249:1995;425.
34. Pinilla C., Appel J.R., Houghten R.A. Tea bag synthesis of positional scanning synthetic combinatorial libraries and their use for mapping antigenic determinants. Methods Mol. Biol. 66:1996;171.
35. Recombinate and kogenate study groups, Prescott R., Nakai H., Saenko E.L., Scharrer I., Nilsson I.M., Humphries J.E., Hurst D., Bray G., Scandella D. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Blood. 89:1997;3663.
36. Saenko E.L., Scandella D. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J. Biol. Chem. 270:1995;13826.
37. Saenko E.L., Scandella D. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor. J. Biol. Chem. 272:1997;18007.
38. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., Mullis K.B., Erlich H.A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:1988;487.
39. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. Santini C., Brennan D., Mennuni C., Hoess R.H., Nicosia A., Cortese R., Luzzago A. Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J. Mol. Biol. 282:1998;125.
41. Scandella D., Mattingly M., de Graaf S., Fulcher C.A. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization. Blood. 74:1989;1618.
42. Scandella D., Timmons L., Mattingly M., Trabold N., Hoyer L.W. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting. Thromb. Haemost. 67:1992;665.
43. Scandella D., Gilbert G.E., Shima M., Nakai H., Eagleson C., Felch M., Prescott R., Rajalakshmi K.J., Hoyer L.W., Saenko E. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. Blood. 86:1995;1811.
44. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386.
45. Shima M., Scandella D., Yoshioka A., Nakai H., Tanaka I., Kamisue S., Terada S., Fukui H. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb. Haemost. 69:1993;240.
46. Shima M., Nakai H., Scandella D., Tanaka I., Sawamoto Y., Kamisue S., Morichika S., Murakami T., Yoshioka A. Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor. Br. J. Haematol. 91:1995;714.
47. Sternberg N., Hoess R.H. Display of peptides and proteins on the surface of bacteriophage λ Proc. Natl. Acad. Sci. U.S.A. 92:1995;1609.
48. Tiarks C., Pechet L., Anderson J., Mole J.E., Humphreys R.E. Characterization of a factor VIII immunogenic site using factor VIII synthetic peptide 1687-1695 and rabbit anti-peptide antibodies. Thromb. Res. 65:1992;301.
49. Toole J.J., Knopf J.L., Wozney J.M., Sultzman L.A., Buecker J.L., Pittman D.D., Kaufman R.J., Brown E., Shoemaker C., Orr E.C.et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature. 312:1984;342.
50. van Dieijen G., Tans G., Rosing J., Hemker H.C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256:1981;3433.
51. van Zonneveld A.-J., van den Berg B.M.M., van Meijer M., Pannekoek H. Identification of functional interaction sites on proteins using bacteriophage-displayed random epitope libraries. Gene. 167:1995;49.
52. Vehar G.A., Keyt B., Eaton D., Rodriguez H., O'Brien D.P., Rotblat F., Oppermann H., Keck R., Wood W.I., Harkins R.N.et al. Structure of human factor VIII. Nature. 312:1984;337.
53. Wang L.-F., Plessis D.H.D., White J.R., Hyatt A.D., Eaton B.T. Use of a gene-targeted phage display random epitope library to map an antigenic determinant on the bluetongue virus outer capsid protein VP5. J. Immunol. Methods. 178:1995;1.
54. Ware J., MacDonald M.J., Lo M., de Graaf S., Fulcher C.A. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide. Blood Coagul. Fibrinolysis. 3:1992;703.
55. Wood W.I., Capon D.J., Simonsen C.C., Eaton D.L., Gitschier J., Keyt B., Seeburg P.H., Smith D.H., Hollingshead P., Wion K.L.et al. Expression of active human factor VIII from recombinant DNA clones. Nature. 312:1984;330.
56. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 33:1985;103.
57. Zhong D., Saenko E.L., Shima M., Felch M., Scandella D. Some human inhibitor antibodies interfere with factor VIII binding to factor IX. Blood. 92:1998;136.
58. Zvi A., Kustanovich I., Feigelson D., Levy R., Eisenstein M., Matsushita S., Richalet-Sécordel P., Regenmortel M.H., Anglister J. NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody. Eur. J. Biochem. 229:1995;178.